![]() |
|
|
Vol. 18, Issue 10, 4085-4095, October 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and Prevents DNA Damage during ReplicationDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN 55455
Submitted December 26, 2006;
Revised June 25, 2007;
Accepted August 3, 2007
Monitoring Editor: Daniel Lew
| ABSTRACT |
|---|
|
|
|---|
and functions as a nuclear chaperone for the catalytic subunit, which is rapidly degraded in the absence of Mcm10. We report here that the interaction between Mcm10 and pol-
is conserved in human cells. We used a small interfering RNA-based approach to deplete Mcm10 in HeLa cells, and we observed that the catalytic subunit of pol-
, p180, was degraded with similar kinetics as Mcm10, whereas the regulatory pol-
subunit, p68, remained unaffected. Simultaneous loss of Mcm10 and p180 inhibited S phase entry and led to an accumulation of already replicating cells in late S/G2 as a result of DNA damage, which triggered apoptosis in a subpopulation of cells. These phenotypes differed considerably from analogous studies in Drosophila embryo cells that did not exhibit a similar arrest. To further dissect the roles of Mcm10 and p180 in human cells, we depleted p180 alone and observed a significant delay in S phase entry and fork progression but little effect on cell viability. These results argue that cells can tolerate low levels of p180 as long as Mcm10 is present to "recycle" it. Thus, human Mcm10 regulates both replication initiation and elongation and maintains genome integrity. | INTRODUCTION |
|---|
|
|
|---|
Mcm10 is a constitutively nuclear DNA binding protein (Merchant et al., 1997
; Burich and Lei, 2003
) that is essential in yeast (Burich and Lei, 2003
). Besides its role in DNA replication, Mcm10 has also been implicated in transcriptional silencing (Liachko and Tye, 2005
). It is important to note that the general protein domain structure of Mcm10 is not unique in Saccharomyces cerevisiae, but it is highly conserved among eukaryotic species (Izumi et al., 2000
; Ricke and Bielinsky, 2006
). Mcm10 has a central oligonucleotide/oligosaccharide binding (OB)-fold (Ricke and Bielinsky, 2006
), a signature motif of RNA- and single-stranded (ss) DNA binding proteins. Thus, it is not surprising that, in vitro, Mcm10 prefers ss over double-stranded (ds) DNA (Fien et al., 2004
). Within the central OB-fold resides a proliferating cell nuclear antigen (PCNA) interacting protein motif (Fien et al., 2004
; Das-Bradoo et al., 2006
), or PIP-box, as well as a hydrophobic stretch, similar to the one found in the mobile loop of heat-shock factor (Hsp) 10 (Ricke and Bielinsky, 2006
). Although the PIP box mediates the interaction with PCNA (Das-Bradoo et al., 2006
), the Hsp10-like domain forms part of the interaction site with the catalytic subunit of DNA polymerase (pol)-
(Ricke and Bielinsky, 2004
, 2006
). Because purified S. pombe Mcm10 coimmunoprecipitates purified p180, the catalytic subunit of pol-
in humans, it is reasonable to conclude that the binding between Mcm10 and pol-
is direct and that it does not require any other mediators. Because Mcm10 is necessary for chromatin association of the entire pol-
/primase complex in budding yeast (Ricke and Bielinsky, 2004
), it probably has a crucial role in lagging strand synthesis. The initiation of individual Okazaki fragments requires the repeated action of pol-
/primase (Nasheuer and Grosse, 1987
) to generate a primed template onto which PCNA can be loaded, and it is conceivable that Mcm10 facilitates the RNA-DNA primer synthesis by pol-
/primase and may also be involved in the subsequent recruitment of PCNA (Das-Bradoo et al., 2006
). Alternatively, Mcm10 itself may function as a primase. Schizosaccharomyces pombe Mcm10 purified from Escherichia coli has been reported to possess primase activity by the virtue of a C-terminal nucleotide transfer domain, which seems to be conserved among species (Fien and Hurwitz, 2006
). The picture that is emerging for the role of Mcm10 in DNA replication is that it is involved in the initiation as well as the elongation steps. During initiation, Mcm10 promotes chromatin association of Cdc45, which, in turn, is likely required to activate the Mcm2-7 helicase (Wohlschlegel et al., 2002
; Gregan et al., 2003
; Sawyer et al., 2004
). On unwinding, replication protein A stabilizes the ssDNA, which allows for the Mcm10-dependent loading of pol-
/primase (Walter and Newport, 2000
). Mcm10 is further necessary to maintain DNA binding of pol-
/primase but not that of Cdc45 (Ricke and Bielinsky, 2004
; Yang et al., 2005
). This is most easily explained by the finding that Mcm10 controls the stability of the catalytic subunit of pol-
, regardless of whether pol-
is bound to chromatin or not (Ricke and Bielinsky, 2004
). Consistent with this notion, we have observed that Mcm10 is in a complex with pol-
/primase throughout the cell cycle in budding yeast (Ricke and Bielinsky, 2006
). Furthermore, overexpression of the catalytic subunit of pol-
, Cdc17/Pol1 in the absence of stoichiometric amounts of Mcm10 leads to rapid protein degradation in S. cerevisiae. In contrast, Cdc17/Pol1 is stable when Mcm10 is co-overexpressed (Ricke and Bielinsky, 2006
). Whether this function of Mcm10 is conserved in other species has not been explored. Similarly, it has remained unclear how Mcm10 contributes to DNA replication in human cells. In HeLa cells, Mcm10 associates with chromatin at the G1/S transition and dissociates after S phase completion (Izumi et al., 2000
, 2001
). Nuclear localization studies using green fluorescent protein (GFP)-tagged Mcm10 further suggested that Mcm10 is involved in the activation of pre-RCs but that it may not have an active role at the replication fork (Izumi et al., 2004
).
To better understand the role of Mcm10 during DNA replication in human cells, we introduced Mcm10-specific small interfering RNA (siRNA) into HeLa cells to deplete cells of Mcm10. After treatment, cells accumulated DNA damage and arrested in late S/G2 phase. Interestingly, depletion of Mcm10 caused a decrease in the catalytic subunit of pol-
, p180, but it had no effect on steady-state levels of the regulatory pol-
subunit, p68, or Cdc45. Together, our results argue that Mcm10 is not only required for replication initiation but also for DNA elongation and that the combined loss of Mcm10 and p180 impedes lagging strand synthesis, resulting in replication fork arrest, DNA damage, and cell death.
| MATERIALS AND METHODS |
|---|
|
|
|---|
-ray source at a dose rate of 2.5 Gy/min. Mcm10- and p180-specific siRNAs were synthesized by Dharmacon RNA Technologies (Lafayette, CO). The control siRNA (with at least 4 mismatches to all known human or mouse mRNA sequences) sense strand was 5'-UAGCGACUAAACACAUCAAUU-3'. Lamin A/C siRNA sense strand was 5'-GGUGGUGACGAUCUGGGCUUU-3'. Mcm10 siRNA sense strands were Mcm10si-1, 5'-GAACGGGACGGAAUGCUAAUU-3', Mcm10si-2, 5'-GCACAAACUUGAUCAUCCAUU-3', Mcm10si-3, 5'-GGAGGUGUGUUUAUCUAUCUU-3' and Mcm10si-4, 5'-GGACGAAUUCCAAAGAAGUUU-3'. Mcm10 SMARTpool was a combination of siRNA1-4. For p180 depletion, a combination of four siRNAs (SMARTpool) was used. The sequences of the sense strands were as follows: p180-1, 5'-GCAGUAACAUCGAUUGUAAUU-3', p180-2, 5'-GACAUUAGACGUUUCAUUAUU-3', p180-3, 5'-UAACAUCGCUGGGAACAUUUU-3', and p180-4, 5'-GCUCAAAGGAUUAGAUAUAUU-3'. SMARTpool siRNAs targeting Mcm10 or p180 were used with the experiments shown in Figures 3, 6, 7, and 8.
Transfections were performed at a starting confluence of 30% for three consecutive times, 24 h apart (Prasanth et al., 2004
), with 100 nM siRNA and Lipofectamine 2000 reagent according to the manufacturer's instructions (Invitrogen).
Antibodies
Anti-Mcm10 antibody was purchased from Bethyl Laboratories (Montgomery, TX), and it was used at a 1:1000 for Western blotting. This antibody only recognizes the unmodified form of Mcm10. Anti-DNA polymerase-
(against the 180-kDa subunit) was a gift from Dr. Irene Dornreiter (Heinrich-Pette-Institut für Experimentelle Virologie and Immunologie, Universität Hamburg, Hamburg, Germany), and it was used at a 1:10 dilution for Western blotting (Dehde et al., 2001
). Anti-p68 (against the B-subunit of DNA polymerase-
) was a gift from Dr. Heinz-Peter Nasheuer (Heinz-Peter Nasheuer, Department of Biochemistry, National University of Ireland, Galway, Ireland), and it was used at a 1:3000 dilution for Western blotting. Anti-lamin A and C antibody (Covance, Princeton, NJ) was used at a 1:1000 dilution for Western blotting. Anti-
-tubulin antibody (Covance) was used at a 1:6000 dilution for Western blotting. Anti-Cdc45 antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was used at a 1:200 dilution for Western blotting. Anti-poly(ADP-ribose) polymerase (PARP) (BD Biosciences PharMingen, San Diego, CA) was used at a 1:2000 for Western blotting. Anti-Chk1 antibody (Santa Cruz Biotechnology) was used at a 1:250 dilution for Western blotting. Anti-Chk2 antibody (Santa Cruz Biotechnology) was used at a 1:250 dilution for Western blotting. Anti-phosphorylated Chk1 (Cell Signaling Technology, Danvers, MA) was used at a 1:1000 dilution for Western blotting. Anti-phosphorylated Chk2 (Cell Signaling Technology) was used at a 1:1000 dilution for Western blotting. Anti-phospho-histone-H2AX (Upstate Biotechnology, Lake Placid, NY) was used at a concentration of 2 µg/ml for immunofluorescence studies. Alexa Fluor 647-coupled anti-histone H3 antibody (against phosphorylated serine 28) was purchased from BD Biosciences PharMingen, and anti-5-bromo-2'-deoxyuridine (BrdU) antibody was from BD Biosciences (San Jose, CA).
Cell Cycle Analysis and Flow Cytometry
For detection of BrdU incorporation and fluorescence-activated cell sorting (FACS) analysis, 106 HeLa cells were labeled with BrdU at a final concentration of 10 µM after treatment with siRNA and incubated for 22 h. For immunostaining of BrdU-incorporated DNA, recovered cells were fixed, permeabilized, and stained with anti-BrdU antibody according to the manufacturer's protocol (BD Biosciences). This was followed by incubation with 7-amino-actinomycin D (7-AAD) for 30 min and subsequent resuspension in staining buffer (3% FBS and 0.09% sodium azide in PBS). BrdU-associated emission (fluorescein isothiocyanate [FITC]; 530 ± 20-nm band-pass filter) and DNA-associated fluorescence (7-AAD; 660 ± 20-nm band-pass filter) were measured by FACSCalibur (BD Biosciences).
Total DNA content was also measured by incubation with propidium iodide (20 µg/106 cell sample) for 30 min at room temperature. Briefly, cells were treated with 100 µg of RNase A (Sigma-Aldrich, St. Louis, MO) for 30 min at 37°C and incubated with 20 µg of propidium iodide (PI) for 30 min at room temperature. DNA-associated fluorescence for PI (620-nm long-pass filter) was measured by FACSCalibur (BD Biosciences). Histograms for DNA content were quantified by ModFit LT (Verity Software House, Topsham, ME).
For staining of phosphorylated histone H3, cells were fixed in ice-cold 70% ethanol for 1 h. After fixation, cells were washed once with ice-cold phosphate-buffered saline (PBS) and then permeablized in PBS with 0.1% Tween 20. Cells were then washed twice with cold PBS containing 1% FBS and resuspended in 100 µl of this buffer with 20 µl of the anti-histone H3 antibody (BD Biosciences PharMingen) per 106 cells for 30 min on ice. Cells were washed once in 1% FBS in PBS buffer, treated with 100 µg of RNase A for 30 min at 37°C, and incubated with 20 µg of propidium iodide for 30 min at room temperature. Histone phosphorylation-associated fluorescence for AlexaFluor (647 nm) and DNA-associated fluorescence for PI (620-nm long-pass filter) were measured by FACSCalibur (BD Biosciences).
Immunofluorescence Staining of
-H2AX
HeLa cells were washed three times in PBS, fixed in 2% paraformaldehyde in PBS for 45 min at room temperature, permeabilized in 0.2% Triton-X-100 in PBS for 5 min at room temperature, blocked in 3% bovine serum albumin/PBS for 30 min at 37°C in a humidified box. Cells were incubated with 2 µg/ml
-H2AX antibody for 1 h in the dark. Then, cells were washed in PBS and stained with 500 ng/ml DAPI for 20 min at room temperature. This was followed by a PBS wash and subsequently, cells were mounted with 10% glycerol in PBS and analyzed with an inverted fluorescence microscope (Eclipse TE 200; Nikon, Tokyo, Japan).
Coimmunoprecipitation
HeLa cells were lysed in buffer A (120 mM NaCl, 0.5% NP-40, 0.1 mM EDTA, 0.5 mM Tris-HCl, pH 8.0, 0.1 mM NaF, 0.1 mM Na3VO4, and 0.1 mM dithiothreitol) and incubated with or without 12.5 µg/ml ethidium bromide for 30 min on ice (Gomez et al., 2006
) or with 100 µg/ml DNase I in the presence of 10 mM MgCl2 for 30 min on ice (Ricke and Bielinsky, 2004
). The lysate was centrifuged at 14,000 x g in a precooled centrifuge for 10 min. The supernatant was incubated with anti-p180 (2 µg/100–500 µg of total protein; Santa Cruz Biotechnology), anti-Mcm10 (4 µg/mg lysate; Bethyl Laboratories), or immunoglobulin (Ig)G (4 µg) for 2 h at 4°C on an orbital shaker. Protein G-Sepharose beads (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom) were then added to the lysate and incubated overnight at 4°C. Beads were pelleted, washed three times with PBS and resuspended in 1X Laemmli buffer.
Analysis of Apoptosis by Flow Cytometry Analysis
Double staining of HeLa cells with Annexin V-FITC and PI were used to discriminate viable cells from early and late apoptotic or dead cells. FITC-conjugated Annexin V and PI were obtained as a kit from BD Biosciences PharMingen. Cultured cells treated with siRNA were collected at indicated time points by centrifugation and washed twice with cold PBS, resuspended in binding buffer, and incubated together with Annexin V-FITC and PI as per manufacturer's protocol. Cells were gently vortexed, incubated at room temperature for 15 min, and then analyzed by flow cytometry within 1 h. Annexin V-associated emission (FITC; 530 ± 20-nm band-pass filter) and DNA associated fluorescence for PI (620-nm long-pass filter) were measured by FACSCalibur (BD Biosciences) (Vermes et al., 1995
).
| RESULTS |
|---|
|
|
|---|
|
(p180 in mammals), we were particularly interested in understanding the relationship between Mcm10 and p180 in human cells (Ricke and Bielinsky, 2004
7% at 72 h, but amounts for both proteins increased to
23% at 96 h (Figure 1A; data not shown). Because transfection with siRNA 1 seemed to result in a more robust down-regulation of Mcm10 than transfection with siRNA 2, we continued to use the former for subsequent experiments. Importantly, expression of p68, the regulatory subunit of pol-
, remained unchanged for both siRNA 1 and 2. The same was true for expression levels of Cdc45, which is recruited to replication origins in a Mcm10-dependent manner (Wohlschlegel et al., 2002
Mcm10 Depletion Inhibits Proliferation and Causes Cell Cycle Arrest
The most obvious consequence of Mcm10 down-regulation was a drastic reduction in the cell number, consistent with a proliferation defect. We also noticed morphological changes (Figure 1C), because the majority of Mcm10-depleted cells displayed an unusual phenotype. Approximately 60% of cells treated with Mcm10-specific siRNA 1 displayed this abnormal phenotype compared with 9% in control siRNA-treated cells 96 h posttransfection. This differs from the phenotype of Orc2-depleted HeLa cells (Prasanth et al., 2004
) and suggests that it is not just a by-product of inducing the RNA silencing pathway, but rather specific to the codepletion of Mcm10 and/or p180 (Figure 1C). To further substantiate that down-regulation of Mcm10 or p180-inhibited cell cycle progression, we labeled cells with BrdU for 22 h before harvest at 48, 72, and 96 h after siRNA treatment. Under the assumption that most BrdU was incorporated during DNA replication, we first determined the number of BrdU-positive, actively cycling cells (Table 1). We observed a dramatic decline in proliferating cells as levels of Mcm10 and p180 decreased (Table 1). This is consistent with roles for Mcm10 and p180 in proliferation. To provide a more accurate measure of the cell cycle distributions in the differently treated cultures over time, we quantified both BrdU-positive and -negative cells in G1, S, and G2/M phase. The results of one representative experiment are shown in Figure 2. Although untreated and control cells showed no or little change in their cell cycle profiles (we noticed a slight delay in S phase in control siRNA-treated cells), the codepletion of Mcm10 and p180 caused an increasing accumulation of cells in G2/M phase (Figure 2B). The G2/M peak showed a broad S phase shoulder in the DNA content profiles (Supplemental Figure S1). In addition, few cells entered S phase between 72 and 96 h (39 vs. 33%), which corresponds to the time window with the highest level of depletion (Figure 1). To ensure that these cell cycle aberrations were not triggered unspecifically, we analyzed lamin-depleted cells and found them to be almost indistinguishable from untreated or control siRNA-treated cells (Supplemental Figure S2). These results argue that codepletion of Mcm10 and p180 inhibits S phase entry in G1 cells and completion of DNA synthesis in S phase cells. The latter notion predicted that Mcm10 siRNA-treated cells might not enter mitosis because of incomplete DNA replication or DNA damage. To directly test this hypothesis, we determined the percentage of cells in which serine 28 of histone H3 was phosphorylated. Unlike the phosphorylation of serine 10, which occurs before cells enter mitosis, phosphorylation at serine 28 is a metaphase-specific marker (Goto et al., 1999
). FACS analysis revealed that the percentage of mitotic cells in untreated, Mcm10 siRNA-treated and control cultures was almost identical and ranged between 2.1 and 2.9%, 72 and 96 h post-siRNA transfection (data not shown). Thus, the majority of Mcm10-depleted cells with apparent 4N DNA content had not entered metaphase. Finally, we also noticed a significant increase in apoptotic cells upon loss of Mcm10 and p180, as indicated by the growing sub-G1 peak in the normal cell cycle profiles (Supplemental Figure S1). The results of our quantification of BrdU-negative cells with less than 2N DNA content are listed in Table 1 and indicate that 96 h after transfection, Mcm10 siRNA-treated cells had a significant increase in cell death above background. These results were confirmed in an independent assay by measuring the amount of Annexin V-positive cells (Supplemental Figure S3). Both experiments showed a higher than threefold increase in apoptosis above background.
|
|
) H2AX foci 72 and 96 h after transfection. For p180-depleted cultures, we detected 21 and 49%
-H2AX-positive cells, whereas in lamin and control siRNA treated cultures only between 5 and 7% of cells exhibited
-H2AX foci (Figure 3). Thus, codepletion of Mcm10 and p180 as well as loss of p180 by itself causes activation of a DNA damage/replication stress response. A more detailed analysis of p180-depleted cells is described further below.
|
|
Interact in Human Cell Extracts
.
|
|
|
70% according to the Annexin V staining in Supplemental Figure S3) had already triggered apoptosis. Moreover, ATM but not ATR is a caspase target (Smith et al., 1999
50% of cells exhibited
-H2AX foci (Figure 3B and Supplemental Figure S4), and Chk1 was markedly phosphorylated (Figure 8). We take these results as evidence that despite the similarities in
-H2AX foci formation, the actual damage inflicted onto the DNA differs depending on whether p180 is down-regulated in combination with Mcm10 or not.
|
| DISCUSSION |
|---|
|
|
|---|
by Mcm10. Most notably, we demonstrate that human Mcm10 has a role in DNA elongation by regulating p180, the catalytic subunit of DNA pol-
. Previous localization studies on Mcm10 in HeLa cells found that Mcm10 foci formation only partly overlapped with nuclear regions in which DNA synthesis occurred and that localization of Mcm10 preceded that of PCNA by 30–60 min (Izumi et al., 2004
The findings that Mcm10 and p180 are coregulated (Figure 1) and that they are physically associated with each other (Figure 5) provide evidence that human Mcm10 might be involved in lagging strand synthesis. Consistent with this hypothesis, we have recently reported that the core of Mcm10 in S. cerevisiae contains an OB-fold domain (Ricke and Bielinsky, 2006
), which mediates binding to ssDNA (Fien et al., 2004
). This OB-fold domain is evolutionarily conserved, and it could allow human Mcm10 to bind to the lagging stand template, facilitating Okazaki fragment initiation by pol-
/primase. Furthermore, Mcm10 could have a role in recycling pol-
in between the initiation of consecutive Okazaki fragments (especially when pol-
levels are low). This model would be consistent with our finding that low levels of p180 are sufficient to support S phase progression (albeit slowly) in the presence but not in the "absence" of Mcm10. Codepletion of p180 and Mcm10 causes DNA damage and apoptosis. DNA damage likely arises from stalled replication forks after uncoupling of leading and lagging strand synthesis (Figure 9). We envision the following scenario to explain these results: in the presence of Mcm10, only p180 is limiting at replication forks. Recycling of p180 by Mcm10 could supply each fork with sufficient p180 to eventually progress through S phase. However, the combined loss of p180 and Mcm10 makes both limiting at replication forks, inhibiting lagging strand synthesis at a large number of forks. These forks can essentially not be restarted as long as Mcm10 and p180 levels remain low, thus causing irreversibly arrested replication forks, which could be processed into DSBs, consistent with the
-H2AX foci and Chk2 activation we observed in this study and the occurrence of apoptosis. However, we have also considered the fact that Mcm10 seems to act further upstream in replication activation than p180 (Ricke and Bielinsky, 2004
), and this may contribute to the differences between Mcm10- and p180 siRNA-treated cultures. Because human Mcm10 likely has a role in pre-RC activation (Wohlschlegel et al., 2002
; Izumi et al., 2004
), loss of Mcm10 could result in a decreased number of activated replication origins. In combination with the elongation defect caused by the loss of p180, Mcm10-depleted cells might simply not have a sufficiently high number of replication forks to duplicate their genome in a timely manner, explaining the accumulation in late S/G2. The only caveat is that this model does not provide an explanation for the DNA damage and apoptosis we observed, because a delay in replication does not necessarily cause these phenotypes (Bielinsky 2003
; Christensen and Tye 2003
; this study).
|
25 kilobases [kb] in KC cells vs. multiple 100 kb in mammals) typically found in embryonic systems (Huberman and Riggs, 1968
One important question that arises from our study is how Mcm10 regulates p180. Our data support the idea that pol-
is in a complex with Mcm10 (Figure 5). Therefor, it is conceivable that Mcm10 interacts directly with the catalytic subunit, as shown for S. pombe Mcm10 (Fien et al., 2004
). In budding yeast, a hydrophobic stretch similar to a domain in the mobile loop of Hsp10 is required to stabilize the catalytic subunit of pol-
, Cdc17/Pol1 (Ricke and Bielinsky, 2006
). Importantly, the Hsp10-like domain in Mcm10 is evolutionarily conserved, and a single amino acid change within this domain drastically reduces the stability of Cdc17/Pol1 (Ricke and Bielinsky, 2006
). We propose that the same domain in human Mcm10 is important for the interaction with p180. Although we do not yet understand the molecular mechanism underlying the association between Mcm10 and p180, our studies firmly establish that Mcm10 is required to stabilize p180 and that this occurs independently of p68 (Figure 1). This is further supported by the finding that p68 has no effect on the half-life of overexpressed p180 in mammalian cells although p68 facilitates the nuclear localization of p180 (Mizuno et al., 1998
, 1999
), and the same is true for the homologues in budding yeast (Ricke and Bielinsky, 2006
). Clearly, future studies are needed to explore how exactly Mcm10 contributes to replication fork progression and maintains genome integrity.
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org). ![]()
Address correspondence to: Anja-Katrin Bielinsky (bieli003{at}umn.edu)
| REFERENCES |
|---|
|
|
|---|
Bielinsky, A. K. (2003). Replication origins: why do we need so many? Cell Cycle 2, 307–309.[Medline]
Burich, R., and Lei, M. (2003). Two bipartite NLSs mediate constitutive nuclear localization of Mcm10. Curr. Genet 44, 195–201.[CrossRef][Medline]
Burma, S., Chen, B. P., Murphy, M., Kurimasa, A., and Chen, D. J. (2001). ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem 276, 42462–42467.
Christensen, T. W., and Tye, B. K. (2003). Drosophila MCM10 interacts with members of the prereplication complex and is required for proper chromosome condensation. Mol. Biol. Cell 14, 2206–2215.
Das-Bradoo, S., Ricke, R. M., and Bielinsky, A. K. (2006). Interaction between PCNA and diubiquitinated Mcm10 is essential for cell growth in budding yeast. Mol. Cell. Biol 26, 4806–4817.
Dehde, S., Rohaly, G., Schub, O., Nasheuer, H. P., Bohn, W., Chemnitz, J., Deppert, W., and Dornreiter, I. (2001). Two immunologically distinct human DNA polymerase alpha-primase subpopulations are involved in cellular DNA replication. Mol. Cell. Biol 21, 2581–2593.
Diffley, J. F., Cocker, J. H., Dowell, S. J., and Rowley, A. (1994). Two steps in the assembly of complexes at yeast replication origins in vivo. Cell 78, 303–316.[CrossRef][Medline]
Ermakova, O. V., Nguyen, L. H., Little, R. D., Chevillard, C., Riblet, R., Ashouian, N., Birshtein, B. K., and Schildkraut, C. L. (1999). Evidence that a single replication fork proceeds from early to late replicating domains in the IgH locus in a non-B cell line. Mol. Cell 3, 321–330.[CrossRef][Medline]
Fien, K., Cho, Y. S., Lee, J. K., Raychaudhuri, S., Tappin, I., and Hurwitz, J. (2004). Primer utilization by DNA polymerase alpha-primase is influenced by its interaction with Mcm10p. J. Biol. Chem 279, 16144–16153.
Fien, K., and Hurwitz, J. (2006). Fission yeast Mcm10p contains primase activity. J. Biol. Chem 281, 22248–222460.
Gambus, A., Jones, R. C., Sanchez-Diaz, A., Kanemaki, M., van Deursen, F., Edmondson, R. D., and Labib, K. (2006). GINS maintains association of Cdc45 with MCM in replisome progression complexes at eukaryotic DNA replication forks. Nat. Cell. Biol 8, 358–366.[CrossRef][Medline]
Gomez, M., Wu, J., Schreiber, V., Dunlap, J., Dantzer, F., Wang, Y., and Liu, Y. (2006). PARP1 Is a TRF2-associated poly(ADP-ribose)polymerase and protects eroded telomeres. Mol. Biol. Cell 17, 1686–1696.
Goto, H. et al. (1999). Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. J. Biol. Chem 274, 25543–25549.
Gregan, J., Lindner, K., Brimage, L., Franklin, R., Namdar, M., Hart, E. A., Aves, S. J., and Kearsey, S. E. (2003). Fission yeast Cdc23/Mcm10 functions after pre-replicative complex formation to promote Cdc45 chromatin binding. Mol. Biol. Cell 14, 3876–3887.
Han, Z., Bhalla, K., Pantazis, P., Hendrickson, E. A., and Wyche, J. H. (1999). Cif (cytochrome c efflux-inducing factor) activity is regulated by Bcl-2 and caspases and correlates with the activation of Bid. Mol. Cell. Biol 19, 1381–1389.
Huberman, J. A., and Riggs, A. D. (1968). On the mechanism of DNA replication in mammalian chromosomes. J. Mol. Biol 32, 327–341.[CrossRef][Medline]
Hyrien, O., Maric, C., and Mechali, M. (1995). Transition in specification of embryonic metazoan DNA replication origins. Science 270, 994–997.
Izumi, M., Yanagi, K., Mizuno, T., Yokoi, M., Kawasaki, Y., Moon, K. Y., Hurwitz, J., Yatagai, F., and Hanaoka, F. (2000). The human homolog of Saccharomyces cerevisiae Mcm10 interacts with replication factors and dissociates from nuclease-resistant nuclear structures in G(2) phase. Nucleic Acids Res 28, 4769–4777.
Izumi, M., Yatagai, F., and Hanaoka, F. (2001). Cell cycle-dependent proteolysis and phosphorylation of human Mcm10. J. Biol. Chem 276, 48526–48531.
Izumi, M., Yatagai, F., and Hanaoka, F. (2004). Localization of human Mcm10 is spatially and temporally regulated during the S phase. J. Biol. Chem 279, 32569–32577.
Kubota, Y., Takase, Y., Komori, Y., Hashimoto, Y., Arata, T., Kamimura, Y., Araki, H., and Takisawa, H. (2003). A novel ring-like complex of Xenopus proteins essential for the initiation of DNA replication. Genes Dev 17, 1141–1152.
Labib, K., Tercero, J. A., and Diffley, J. F. (2000). Uninterrupted MCM2–7 function required for DNA replication fork progression. Science 288, 1643–1647.
Lai, J. S., and Herr, W. (1992). Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations. Proc. Natl. Acad. Sci. USA 89, 6958–6962.
Liachko, I., and Tye, B. K. (2005). Mcm10 is required for the maintenance of transcriptional silencing in Saccharomyces cerevisiae. Genetics 171, 503–515.
MacAlpine, D. M., Rodriguez, H. K., and Bell, S. P. (2004). Coordination of replication and transcription along a Drosophila chromosome. Genes Dev 18, 3094–3105.
Madine, M. A., Khoo, C. Y., Mills, A. D., Musahl, C., and Laskey, R. A. (1995). The nuclear envelope prevents reinitiation of replication by regulating the binding of MCM3 to chromatin in Xenopus egg extracts. Curr. Biol 5, 1270–1279.[CrossRef][Medline]
Mendez, J., and Stillman, B. (2003). Perpetuating the double helix: molecular machines at eukaryotic DNA replication origins. Bioessays 25, 1158–1167.[CrossRef][Medline]
Merchant, A. M., Kawasaki, Y., Chen, Y., Lei, M., and Tye, B. K. (1997). A lesion in the DNA replication initiation factor Mcm10 induces pausing of elongation forks through chromosomal replication origins in Saccharomyces cerevisiae. Mol. Cell. Biol 17, 3261–3271.
Mizuno, T., Ito, N., Yokoi, M., Kobayashi, A., Tamai, K., Miyazawa, H., and Hanaoka, F. (1998). The second-largest subunit of the mouse DNA polymerase alpha-primase complex facilitates both production and nuclear translocation of the catalytic subunit of DNA polymerase alpha. Mol. Cell. Biol 18, 3552–3562.
Mizuno, T., Yamagishi, K., Miyazawa, H., and Hanaoka, F. (1999). Molecular architecture of the mouse DNA polymerase alpha-primase complex. Mol. Cell. Biol 19, 7886–7896.
Moyer, S. E., Lewis, P. W., and Botchan, M. R. (2006). Isolation of the Cdc45/Mcm2–7/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork helicase. Proc. Natl. Acad. Sci. USA 103, 10236–10241.
Nasheuer, H. P., and Grosse, F. (1987). Immunoaffinity-purified DNA polymerase alpha displays novel properties. Biochemistry 26, 8458–8466.[CrossRef][Medline]
Osborn, A., Elledge, S., and Zou, L. (2002). Checking on the fork: the DNA-replication stress-response pathway. Trends Cell Biol 12, 509–516.[CrossRef][Medline]
Pacek, M., Tutter, A. V., Kubota, Y., Takisawa, H., and Walter, J. C. (2006). Localization of MCM2–7, Cdc45, and GINS to the site of DNA unwinding during eukaryotic DNA replication. Mol. Cell 21, 581–587.[CrossRef][Medline]
Pacek, M., and Walter, J. C. (2004). A requirement for MCM7 and Cdc45 in chromosome unwinding during eukaryotic DNA replication. EMBO J 23, 3667–3676.[CrossRef][Medline]
Patel, T., Gores, G. J., and Kaufmann, S. H. (1996). The role of proteases during apoptosis. FASEB J 10, 587–597.[Abstract]
Prasanth, S. G., Prasanth, K. V., Siddiqui, K., Spector, D. L., and Stillman, B. (2004). Human Orc2 localizes to centrosomes, centromeres and heterochromatin during chromosome inheritance. EMBO J 23, 2651–2663.[CrossRef][Medline]
Ricke, R. M., and Bielinsky, A. K. (2004). Mcm10 regulates the stability and chromatin association of DNA polymerase-alpha. Mol. Cell 16, 173–185.[CrossRef][Medline]
Ricke, R. M., and Bielinsky, A. K. (2006). A conserved Hsp10-like domain in Mcm10 is required to stabilize the catalytic subunit of DNA polymerase-alpha in budding yeast. J. Biol. Chem 281, 18414–18425.
Sawyer, S. L., Cheng, I. H., Chai, W., and Tye, B. K. (2004). Mcm10 and Cdc45 cooperate in origin activation in Saccharomyces cerevisiae. J. Mol. Biol 340, 195–202.[CrossRef][Medline]
Schwacha, A., and Bell, S. P. (2001). Interactions between two catalytically distinct MCM subgroups are essential for coordinated ATP hydrolysis and DNA replication. Mol. Cell 8, 1093–1104.[CrossRef][Medline]
Shechter, D., Ying, C. Y., and Gautier, J. (2004). DNA unwinding is an Mcm complex-dependent and ATP hydrolysis-dependent process. J. Biol. Chem 279, 45586–45593.
Smith, G., D'Adda di Fagagna, F., Lakin, N., and Jackson, S. (1999). Cleavage and inactivation of ATM during apoptosis. Mol. Cell. Biol 19, 6076–6084.
Solomon, N. A., Wright, M. B., Chang, S., Buckley, A. M., Dumas, L. B., and Gaber, R. F. (1992). Genetic and molecular analysis of DNA43 and DNA 52, two new cell-cycle genes in Saccharomyces cerevisiae. Yeast 8, 273–289.[CrossRef][Medline]
Takayama, Y., Kamimura, Y., Okawa, M., Muramatsu, S., Sugino, A., and Araki, H. (2003). GINS, a novel multiprotein complex required for chromosomal DNA replication in budding yeast. Genes Dev 17, 1153–1165.
Vermes, I., Haanen, C., Steffens-Nakken, H., and Reutelingsperger, C. (1995). A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184, 39–51.[CrossRef][Medline]
Walter, J., and Newport, J. (2000). Initiation of eukaryotic DNA replication: origin unwinding and sequential chromatin association of Cdc45, RPA, and DNA polymerase alpha. Mol. Cell 5, 617–627.[CrossRef][Medline]
Walter, J., and Newport, J. W. (1997). Regulation of replicon size in Xenopus egg extracts. Science 275, 993–995.
Ward, I. M., and Chen, J. (2001). Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem 276, 47759–47762.
Wohlschlegel, J. A., Dhar, S. K., Prokhorova, T. A., Dutta, A., and Walter, J. C. (2002). Xenopus Mcm10 binds to origins of DNA replication after Mcm2–7 and stimulates origin binding of Cdc45. Mol. Cell 9, 233–240.[CrossRef][Medline]
Yang, X., Gregan, J., Lindner, K., Young, H., and Kearsey, S. E. (2005). Nuclear distribution and chromatin association of DNA polymerase alpha-primase is affected by TEV protease cleavage of Cdc23 (Mcm10) in fission yeast. BMC Mol. Biol 6, 13.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
C. Lee, I. Liachko, R. Bouten, Z. Kelman, and B. K. Tye Alternative Mechanisms for Coordinating Polymerase {alpha} and MCM Helicase Mol. Cell. Biol., January 15, 2010; 30(2): 423 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Zolotukhin, H. Uranishi, S. Lindtner, J. Bear, G. N. Pavlakis, and B. K. Felber Nuclear export factor RBM15 facilitates the access of DBP5 to mRNA Nucleic Acids Res., November 1, 2009; 37(21): 7151 - 7162. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Im, S.-H. Ki, A. Farina, D.-S. Jung, J. Hurwitz, and J.-K. Lee Assembly of the Cdc45-Mcm2-7-GINS complex in human cells requires the Ctf4/And-1, RecQL4, and Mcm10 proteins PNAS, September 15, 2009; 106(37): 15628 - 15632. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Warren, H. Huang, E. Fanning, W. J. Chazin, and B. F. Eichman Physical Interactions between Mcm10, DNA, and DNA Polymerase {alpha} J. Biol. Chem., September 4, 2009; 284(36): 24662 - 24672. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, J. S. Campbell, C. Mitchell, R. S. McMahan, X. Yu, K. J. Riehle, R. E. Bumgarner, and N. Fausto Relationships between Deficits in Tissue Mass and Transcriptional Programs after Partial Hepatectomy in Mice Am. J. Pathol., September 1, 2009; 175(3): 947 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Casteel, S. Zhuang, Y. Zeng, F. W. Perrino, G. R. Boss, M. Goulian, and R. B. Pilz A DNA Polymerase-{alpha}{middle dot}Primase Cofactor with Homology to Replication Protein A-32 Regulates DNA Replication in Mammalian Cells J. Biol. Chem., February 27, 2009; 284(9): 5807 - 5818. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhao, R. J. Madden-Fuentes, B. X. Lou, J. M. Pipas, J. Gerhardt, C. J. Rigell, and E. Fanning Ataxia Telangiectasia-Mutated Damage-Signaling Kinase- and Proteasome-Dependent Destruction of Mre11-Rad50-Nbs1 Subunits in Simian Virus 40-Infected Primate Cells J. Virol., June 1, 2008; 82(11): 5316 - 5328. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||